@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZC894TQQ-C
  skos:prefLabel "Morphinans"@en, "Morphinanes"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-DMDWFNCH-6 .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-DMDWFNCH-6
  mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-SBNWSM1T-R, jvr:-XV06LPML-W, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-NKM836P1-M, jvr:-TJHVZCRZ-0, jvr:-NB0XHT3S-N, jvr:-G4R176S9-J, jvr:-W6SQV79N-S, jvr:-H7K65Q8S-Z, jvr:-G30ZJ446-J, jvr:-THHNVC7V-3, jvr:-WK5F724J-1, jvr:-NFTHND7Q-8, jvr:-D0F21513-5, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-T9HQD7ST-J, jvr:-BT300B3G-Q, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-L6C0XPHT-4, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5 ;
  skos:hiddenLabel "Nalorphine Hydrochloride"@en, "Nalorphine, L-tartrate (1:1)"@en, "Lethidrone"@en, "Nalorphine Hydrobromide"@en, "Chlorhydrate de nalorphine"@fr, "Bromhydrate de nalorphine"@fr, "Nalorphine, (14 alpha)-Isomer"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D009269> ;
  skos:definition "A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete."@en ;
  skos:altLabel "Allylnormorphine"@en, "57-29-4 (HCl)"@fr, "57-29-4 (HCl)"@en, "U59WB2WRY2"@fr, "U59WB2WRY2"@en, "62-67-9 (Nalorphine)"@en, "62-67-9 (Nalorphine)"@fr, "1041-90-3 (HBr)"@en, "1041-90-3 (HBr)"@fr, "97889-94-6 (L-tartrate (1:1))"@fr, "121348-96-7 ((14 alpha)-isomer)"@fr, "121348-96-7 ((14 alpha)-isomer)"@en, "Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-"@fr, "Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-"@en, "97889-94-6 (L-tartrate (1:1))"@en, "9FPE56Z2TW"@fr, "9FPE56Z2TW"@en, "1OLB66508A"@fr, "1OLB66508A"@en ;
  a mesh:Descriptor, skos:Concept ;
  mesh:pharmacologicalAction jvr:-KQW1R3Q5-R ;
  dc:established "1966-01-01"^^xsd:date ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:broader jvr:-ZC894TQQ-C ;
  dc:modified "2016-05-31"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:prefLabel "Nalorphine"@en, "Nalorphine"@fr .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-KQW1R3Q5-R
  skos:prefLabel "Antagonistes narcotiques"@fr, "Narcotic Antagonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .